"Transfuze a hematologie dnes" . "[0E3E36345FFD]" . "RIV/00216224:14310/03:00008586" . "Proch\u00E1zkov\u00E1, Dagmar" . "Gajdo\u0161, P." . . "Z\u016Fna, Ji\u0159\u00ED" . . "132-142" . "V\u00E1vra, V\u00E1clav" . . "Sedl\u00E1\u010Dek, Ivo" . . . . "14310" . . . . "The incidence and teatment of relapse of childhood acute lymphoblastic leukemia in the Czech Republic between 1990-2000"@en . "Kope\u010Dn\u00E1, Lenka" . . "634232" . "1213-5763" . . . . . "RIV/00216224:14310/03:00008586!RIV08-GA0-14310___" . "\u00DAsp\u011B\u0161n\u00E1 l\u00E9\u010Deba relapsu akutn\u00ED lymfoblastick\u00E9 leuk\u00E9mie (ALL) je jednou z nejv\u011Bt\u0161\u00EDch v\u00FDzev d\u011Btsk\u00E9 hematoonkologie na po\u010D\u00E1tku 21. stolet\u00ED. Auto\u0159i analyzovali skupinu 85 d\u011Bt\u00ED, kter\u00E9 byly v 90 letech l\u00E9\u010Deny protokoly ALL-BFM 95 a prod\u011Blaly v obdob\u00ED \u010Derven 1990-prosinec 2000 prvn\u00ED relaps. Praavd\u011Bpodobnost 4let\u00E9ho EFS byla pro celou skupinu 16,7% (SE %) a celkov\u00E9p\u0159e\u017Eit\u00ED 22,8% (SE 5%). L\u00E9\u010Dba relapsu ALL byla sjednocena v roce 1996 podle protokolu ASS-REZ BFM 96. I kdy\u017E do\u0161lo k v\u00FDznamn\u00E9mu zv\u00FD\u0161en\u00ED \u00FAsp\u011B\u0161nosti v dosaaa\u017Een\u00ED remise (83%) ve srovn\u00E1n\u00ED s p\u0159edchoz\u00ED l\u00E9\u010Dbou (,6%) celkov\u00E9 v\u00FDsledky se nezlep\u0161ily. Z 55 d\u011Bt\u00ED, kter\u00E9 dos\u00E1hly remise bylo 26 (47,3%) l\u00E9\u010Deno chemoterapi\u00ED, 21 (38,2%) podstoupilo alogenn\u00ED SCT a 8 (14,5)autologn\u00ED SCT. \u010Casn\u00FD relaps v pr\u016Fb\u011Bhu inici\u00E1ln\u00ED chemoterapie nebo kr\u00E1tce po jej\u00EDm skon\u010Den\u00ED prod\u011Blalo 78,8% d\u011Bt\u00ED. EPS d\u011Bt\u00ED s velmi \u010Dasn\u00FDm relapsem byl 6,7% a d\u011Bt\u00ED s relapsem \u010Dasn\u00FDm 18,2%. O pozn\u00E1n\u00ED lep\u0161\u00ED byly v\u00FDsledky l\u00E9\u010Dby u d\u011Bt\u00ED s pozdn\u00EDm relapsem, kde se podaaa\u0159ilo vyl\u00E9\u010Dit 37,8% pacient\u016F. Nej\u010Dast\u011Bj\u0161" . . "The incidence and teatment of relapse of childhood acute lymphoblastic leukemia in the Czech Republic between 1990-2000"@en . "V\u00FDskyt a l\u00E9\u010Dba relapsu d\u011Btsk\u00E9 akutn\u00ED lymfoblastick\u00E9 leuk\u00E9mie v \u010Cesk\u00E9 republice v letech 1990-2000" . "Sm\u00ED\u0161ek, P." . "2003/9" . "Hru\u0161\u00E1k, Petr" . . "3" . . "\u00DAsp\u011B\u0161n\u00E1 l\u00E9\u010Deba relapsu akutn\u00ED lymfoblastick\u00E9 leuk\u00E9mie (ALL) je jednou z nejv\u011Bt\u0161\u00EDch v\u00FDzev d\u011Btsk\u00E9 hematoonkologie na po\u010D\u00E1tku 21. stolet\u00ED. Auto\u0159i analyzovali skupinu 85 d\u011Bt\u00ED, kter\u00E9 byly v 90 letech l\u00E9\u010Deny protokoly ALL-BFM 95 a prod\u011Blaly v obdob\u00ED \u010Derven 1990-prosinec 2000 prvn\u00ED relaps. Praavd\u011Bpodobnost 4let\u00E9ho EFS byla pro celou skupinu 16,7% (SE %) a celkov\u00E9p\u0159e\u017Eit\u00ED 22,8% (SE 5%). L\u00E9\u010Dba relapsu ALL byla sjednocena v roce 1996 podle protokolu ASS-REZ BFM 96. I kdy\u017E do\u0161lo k v\u00FDznamn\u00E9mu zv\u00FD\u0161en\u00ED \u00FAsp\u011B\u0161nosti v dosaaa\u017Een\u00ED remise (83%) ve srovn\u00E1n\u00ED s p\u0159edchoz\u00ED l\u00E9\u010Dbou (,6%) celkov\u00E9 v\u00FDsledky se nezlep\u0161ily. Z 55 d\u011Bt\u00ED, kter\u00E9 dos\u00E1hly remise bylo 26 (47,3%) l\u00E9\u010Deno chemoterapi\u00ED, 21 (38,2%) podstoupilo alogenn\u00ED SCT a 8 (14,5)autologn\u00ED SCT. \u010Casn\u00FD relaps v pr\u016Fb\u011Bhu inici\u00E1ln\u00ED chemoterapie nebo kr\u00E1tce po jej\u00EDm skon\u010Den\u00ED prod\u011Blalo 78,8% d\u011Bt\u00ED. EPS d\u011Bt\u00ED s velmi \u010Dasn\u00FDm relapsem byl 6,7% a d\u011Bt\u00ED s relapsem \u010Dasn\u00FDm 18,2%. O pozn\u00E1n\u00ED lep\u0161\u00ED byly v\u00FDsledky l\u00E9\u010Dby u d\u011Bt\u00ED s pozdn\u00EDm relapsem, kde se podaaa\u0159ilo vyl\u00E9\u010Dit 37,8% pacient\u016F. Nej\u010Dast\u011Bj\u0161"@cs . . "10"^^ . "V\u00FDskyt a l\u00E9\u010Dba relapsu d\u011Btsk\u00E9 akutn\u00ED lymfoblastick\u00E9 leuk\u00E9mie v \u010Cesk\u00E9 republice v letech 1990-2000"@cs . "CZ - \u010Cesk\u00E1 republika" . . "Successful teratment of relapsed acute lympholastic leukemia (ALL) is one of the biggest challenges in pediatric hematooncology at the beginning of the 21st century. The authors analyze a group of 85 children suffering first relapse of ALL in the Czech Republic between 1990-2000. The probability of 4-year event-free survival (EFS) was 16,7%(SE 5%) and that of overall survival 22,8% (SE 5%) for the whole group. In the 1996 treatment of children with relapse of ALL was unified according to the German protocol ALL-REZ BFM 96. Twenty-six (47,3%) out of 55 children achieving cesond remission were treated by chemotherapy alone, 21 (38,2%)children underwent allogeneic stem-cell transplatation"@en . "Star\u00FD, Jan" . "8"^^ . . "V\u00FDskyt a l\u00E9\u010Dba relapsu d\u011Btsk\u00E9 akutn\u00ED lymfoblastick\u00E9 leuk\u00E9mie v \u010Cesk\u00E9 republice v letech 1990-2000"@cs . . "P(GP301/03/P041)" . . "11"^^ . "V\u00FDskyt a l\u00E9\u010Dba relapsu d\u011Btsk\u00E9 akutn\u00ED lymfoblastick\u00E9 leuk\u00E9mie v \u010Cesk\u00E9 republice v letech 1990-2000" . "Hrstkov\u00E1, Hana" . "acute lymphoblastic leukemia; relapse; children; stem-cell transplantation; chemotherapy; BFM protocol"@en . . "Hak, J." . . .